Jingdong Zhang

机构：Standard Bio (Norway), Ganzhou People's Hospital, Tongren Hospital, Liaoning Cancer Hospital & Institute · ORCID：0000-0002-0711-2764

发表论文 239 篇 · 总被引 5445 次 · h-index 31

代表论文

• Epithelial-mesenchymal transition in colorectal cancer metastasis and progression: molecular mechanisms and therapeutic strategies (2025 · Cell Death Discovery · 被引 55)
• Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trial (2025 · Signal Transduction and Targeted Therapy · 被引 20)
• Domestication and feedback: bidirectional hijacking in pancreatic ductal adenocarcinoma microenvironment (2025 · Frontiers in Immunology · 被引 5)
• Laser-induced WO3-decorated porous graphene for portable and self-powered photoelectrochemical aptasensing (2025 · Microchimica Acta · 被引 4)
• Efficacy and safety of garsorasib in patients with KRAS G12C-mutated advanced pancreatic cancer (2025 · British Journal of Cancer · 被引 2)
• Early detection of positive urine culture in patients with urolithiasis: a machine learning model with dynamic online nomogram (2025 · Annals of Medicine · 被引 2)